tradmap

COSM Earnings Cosmos Health Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$33 $1M $2M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $33M $65M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$19M -$9M $820786 $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $10M $20M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$14M -$7M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–60 of 60
Q2 20262026-06-30-0.102026-08-1810-Q
Q1 20262026-03-31-0.062026-05-2010-Q
Q4 2025 (derived)2025-12-31-0.332026-04-1510-K
FY 20252025-12-31-0.632026-04-1510-K
Q3 20252025-09-30-0.172025-11-1410-Q
Q2 20252025-06-30-0.102025-08-1810-Q
Q1 20252025-03-31-0.032025-05-1510-Q
Q4 2024 (derived)2024-12-31-0.462025-04-1510-K
FY 20242024-12-31-1.172025-04-1510-K
Q3 20242024-09-30-0.452024-11-1410-Q
Q2 20242024-06-30-0.152024-08-1910-Q
Q1 20242024-03-31-0.112024-08-1910-Q
Q4 2023 (derived)2023-12-31-1.752024-08-0510-K
FY 20232023-12-31-2.152024-08-0510-K
Q3 20232023-09-30-0.272023-11-2010-Q
Q2 20232023-06-30-0.092023-08-1510-Q
Q1 20232023-03-31-0.042023-05-1610-Q
Q4 2022 (derived)2022-12-310.002023-04-1210-K
FY 20222022-12-31-33.162023-04-1210-K
Q3 20222022-09-30-1.932022-11-1410-Q
Q2 20222022-06-30-23.372022-08-1910-Q
Q1 20222022-03-31-7.862022-05-1710-Q
Q4 2021 (derived)2021-12-31-16.382022-04-1510-K
FY 20212021-12-31-23.742022-04-1510-K
Q3 20212021-09-30-0.112021-11-1510-Q
Q2 20212021-06-30-3.752021-08-1610-Q
Q1 20212021-03-31-3.502021-05-1710-Q
Q4 2020 (derived)2020-12-31-1.502021-04-1510-K
FY 20202020-12-311.502021-04-1510-K
Q3 20202020-09-301.502020-11-1610-Q
Q2 20202020-06-302.502020-08-1310-Q
Q1 20202020-03-31-1.002020-05-1510-Q
Q4 2019 (derived)2019-12-310.252020-04-1410-K
FY 20192019-12-31-6.252020-04-1410-K
Q3 20192019-09-30-3.002019-11-1410-Q
Q2 20192019-06-30-3.002019-08-1910-Q
Q1 20192019-03-31-0.502019-05-2010-Q
Q4 2018 (derived)2018-12-31-18.502019-04-1810-K
FY 20182018-12-31-17.002019-04-1810-K
Q3 20182018-09-306.002018-11-1310-Q
Q2 20182018-06-301.502018-08-1410-Q
Q1 20182018-03-31-6.00——
FY 20172017-12-31-12.252018-04-1710-K
Q3 20172017-09-30-0.50——
Q2 20172017-06-30-1.75——
Q4 2016 (derived)2016-12-312018525.002017-04-1710-K
FY 20162016-12-312018525.002017-04-1710-K
Q3 20162016-09-300.002016-11-1710-Q
Q2 20162016-06-300.002016-08-1810-Q
Q1 20162016-03-310.002016-05-1610-Q
Q4 2015 (derived)2015-12-31-1.252016-04-2010-K
FY 20152015-12-31-1.252016-04-2010-K
Q3 20152015-09-300.002015-11-2310-Q
Q2 20152015-06-300.002015-08-2110-Q
Q1 20152015-03-310.002015-05-1510-Q
Q4 2014 (derived)2014-12-310.002015-04-1510-K
FY 20142014-12-311.252015-04-1510-K
Q3 20142014-09-301.002014-11-1310-Q
Q2 20142014-06-300.252014-08-1110-Q
Q1 20142014-03-310.002014-05-2010-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.